UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32846) 32846
Magazine Article (58) 58
Book Chapter (51) 51
Dissertation (38) 38
Book / eBook (24) 24
Publication (11) 11
Web Resource (8) 8
Journal / eJournal (4) 4
Conference Proceeding (2) 2
Newsletter (2) 2
Streaming Video (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31828) 31828
science & technology (23193) 23193
life sciences & biomedicine (22736) 22736
male (16900) 16900
female (15979) 15979
child (13432) 13432
hematology (10897) 10897
oncology (10881) 10881
adolescent (10613) 10613
adult (9355) 9355
child, preschool (9278) 9278
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (8187) 8187
precursor cell lymphoblastic leukemia-lymphoma - genetics (6676) 6676
middle aged (5937) 5937
infant (5771) 5771
leukemia (5076) 5076
precursor cell lymphoblastic leukemia-lymphoma - pathology (5034) 5034
precursor cell lymphoblastic leukemia-lymphoma - therapy (4727) 4727
pediatrics (4107) 4107
prognosis (4006) 4006
antineoplastic combined chemotherapy protocols - therapeutic use (3693) 3693
acute lymphoblastic leukemia (3585) 3585
aged (3527) 3527
abridged index medicus (3367) 3367
precursor cell lymphoblastic leukemia-lymphoma - complications (3179) 3179
treatment outcome (3097) 3097
cancer (3004) 3004
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (2834) 2834
animals (2791) 2791
acute lymphocytic leukemia (2690) 2690
risk factors (2654) 2654
precursor cell lymphoblastic leukemia-lymphoma - mortality (2506) 2506
remission induction (2431) 2431
recurrence (2283) 2283
precursor cell lymphoblastic leukemia-lymphoma - metabolism (2090) 2090
precursor cell lymphoblastic leukemia-lymphoma - immunology (2087) 2087
retrospective studies (2062) 2062
chemotherapy (2041) 2041
young adult (2012) 2012
children (1961) 1961
research (1913) 1913
mice (1859) 1859
immunophenotyping (1669) 1669
antineoplastic agents - therapeutic use (1661) 1661
follow-up studies (1603) 1603
care and treatment (1577) 1577
transplantation (1560) 1560
health aspects (1553) 1553
immunology (1548) 1548
cell line, tumor (1535) 1535
disease-free survival (1534) 1534
tumor cells, cultured (1494) 1494
acute lymphatic leukemia (1474) 1474
survival rate (1470) 1470
precursor cell lymphoblastic leukemia-lymphoma - blood (1456) 1456
genetic aspects (1453) 1453
acute disease (1427) 1427
flow cytometry (1418) 1418
leukemia-lymphoma, adult t-cell - pathology (1413) 1413
analysis (1377) 1377
hemic and lymphatic diseases (1373) 1373
polymerase chain reaction (1369) 1369
translocation, genetic (1367) 1367
bone marrow transplantation (1328) 1328
combined modality therapy (1320) 1320
precursor cell lymphoblastic leukemia-lymphoma - epidemiology (1296) 1296
time factors (1281) 1281
antineoplastic combined chemotherapy protocols - adverse effects (1232) 1232
transplantation, homologous (1228) 1228
t cells (1196) 1196
infant, newborn (1172) 1172
gene expression (1164) 1164
hematopoietic stem cell transplantation (1144) 1144
mutation (1124) 1124
survival analysis (1120) 1120
apoptosis (1113) 1113
leukemia-lymphoma, adult t-cell - genetics (1107) 1107
genetics & heredity (1094) 1094
base sequence (1091) 1091
cell biology (1084) 1084
bone marrow - pathology (1071) 1071
case-control studies (1060) 1060
molecular sequence data (1036) 1036
karyotyping (1024) 1024
precursor b-cell lymphoblastic leukemia-lymphoma - genetics (1010) 1010
general & internal medicine (1005) 1005
methotrexate - administration & dosage (1003) 1003
medicine, general & internal (988) 988
aids/hiv (982) 982
medicine & public health (977) 977
biochemistry & molecular biology (970) 970
philadelphia chromosome (955) 955
hematology, oncology and palliative medicine (942) 942
diagnosis, differential (927) 927
lymphatic leukemia (920) 920
pathology (914) 914
aged, 80 and over (908) 908
all (901) 901
chromosome aberrations (882) 882
stem cells (878) 878
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Periodical Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29951) 29951
Japanese (1259) 1259
Chinese (1118) 1118
Spanish (377) 377
French (350) 350
German (260) 260
Russian (250) 250
Polish (247) 247
Portuguese (104) 104
Italian (73) 73
Danish (33) 33
Czech (32) 32
Hungarian (32) 32
Dutch (27) 27
Korean (18) 18
Norwegian (17) 17
Serbian (16) 16
Croatian (11) 11
Swedish (11) 11
Turkish (11) 11
Ukrainian (9) 9
Finnish (8) 8
Romanian (7) 7
Slovak (7) 7
Hebrew (5) 5
Bosnian (3) 3
Bulgarian (1) 1
Greek (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica (Roma), ISSN 1592-8721, 05/2007, Volume 92, Issue 5, pp. 612 - 618
From the Hematology and Bone Marrow Transplantation Units of Ospedali Riuniti Bergamo (OS, BP, MT, VG, AS, MCZ, EO, AG, TI, CM, TB, RB, AR); Spedali Civili... 
ALL | Allogeneic transplantation | MRD | Adult ALL | Life Sciences & Biomedicine | Hematology | Science & Technology | Translocation, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - surgery | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Gene Deletion | Fusion Proteins, bcr-abl - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Basic Helix-Loop-Helix Transcription Factors - genetics | Hematopoietic Stem Cell Transplantation | Survival Rate | Combined Modality Therapy | Remission Induction | Adolescent | Survival Analysis | Oncogene Proteins, Fusion - blood | Kinetics | Transplantation Conditioning | Cohort Studies | Piperazines - administration & dosage | Clinical Trials as Topic - statistics & numerical data | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Risk | Transplantation, Homologous | Neoplasm, Residual | Multicenter Studies as Topic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Polymerase Chain Reaction | Adult | Female | Myeloid-Lymphoid Leukemia Protein - blood | Gene Rearrangement, B-Lymphocyte | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | T-Cell Acute Lymphocytic Leukemia Protein 1 | Leukemia-Lymphoma, Adult T-Cell - genetics | Leukemia-Lymphoma, Adult T-Cell - surgery | Pyrimidines - administration & dosage | Gene Rearrangement, T-Lymphocyte | Leukemia-Lymphoma, Adult T-Cell - mortality | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Imatinib Mesylate | Biomarkers, Tumor - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia-Lymphoma, Adult T-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzamides | Index Medicus
Journal Article
Journal Article
Blood, ISSN 1528-0020, 08/2011, Volume 118, Issue 8, pp. 2077 - 2084
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2013, Volume 31, Issue 34, pp. 4333 - 4342
Journal Article
Blood, ISSN 1528-0020, 12/2015, Volume 126, Issue 24, pp. 2570 - 2577
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 09/2010, Volume 28, Issue 27, pp. 4177 - 4183
Journal Article
British journal of haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
Summary This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Index Medicus | Haematological Malignancy | Research Paper
Journal Article
Journal of immunology research, ISSN 2314-7156, 06/2019, Volume 2019, pp. 1 - 11
Acute lymphoblastic leukemia (ALL) is the most common cancer among children. Recent advances in chemotherapy have made ALL a curable hematological malignancy.... 
Life Sciences & Biomedicine | Immunology | Science & Technology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Receptor, Notch3 - metabolism | Central Nervous System - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Central Nervous System - pathology | Signal Transduction - genetics | Receptor, Notch1 - metabolism | Disease Progression | Receptors, CXCR4 - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology | Tumor Microenvironment - immunology | Chemokine CXCL12 - metabolism | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Adult | Receptor, Notch3 - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - immunology | Receptor, Notch1 - genetics | Child | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Transformation | Deregulation | Pathogenesis | Leukemia | Central nervous system | Oncology | Lymphocytes T | Malignancy | Lymphocytes | Bone marrow | Lymphocyte transformation | Children | Acute lymphatic leukemia | Hematology | Stroma | Lymphatic leukemia | CXCR4 protein | Chemotherapy | Molecular modelling | Lymphocytes B | MicroRNAs | Stem cells | Ligands | Lymphomas | Mutation | Chemokines | Cancer | Apoptosis | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 07/2018, Volume 9, Issue 1, pp. 2670 - 12
Journal Article